NCT02141425View on ClinicalTrials.gov

A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP015K in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

16

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions

Healthy VolunteersPharmacokinetics of ASP015K

Interventions

DRUG

ASP015K

oral

DRUG

Placebo

oral

Trial Locations (1)

91206

California Clinical Trials Medical Group/Parexel, Glendale

Sponsors

Collaborators (1)

Janssen Biotech, Inc.

All Listed Sponsors

collaborator

Janssen Biotech, Inc.

INDUSTRY

lead

Astellas Pharma Global Development, Inc.

INDUSTRY

NCT02141425 - A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP015K in Healthy Subjects | Biotech Hunter | Biotech Hunter